Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

The success of Eli Lilly’s Zepbound, a challenger to Novo’s Wegovy, has prompted comparisons to a similar scenario, when ...

Europe's STOXX 600 share index closed at a record high on Friday as companies and sectors exposed to China continued to rally ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

WW International Inc. ousted Chief Executive Officer Sima Sistani after a tumultuous two-and-a-half year tenure at the diet ...

The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam.Most Read from ...

Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...

Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of ...